U.S. Residential REITs Stock News

Investors may be wondering whether Amazon.com stock still offers value after a long run in the spotlight, or if expectations already do the heavy lifting for the current price. The stock last closed at US$264.14, with returns of 6.3% over the past month, 16.6% year to date and 28.5% over the past year, while the return over the last 7 days declined 3.1%. Recent headlines have focused on Amazon.com's expansion across its retail and cloud businesses as well as the continued build out of...

Boston Scientific (NYSE:BSX) shareholders approved amendments to the corporate charter at the latest annual meeting. The changes remove supermajority voting requirements for certain decisions. The charter now includes exculpation provisions for specific officers, consistent with Delaware law. These updates adjust how shareholder rights and officer accountability are structured going forward. Boston Scientific operates as a global medical device company, so governance decisions sit alongside...

In its recent past fiscal second quarter update, National Fuel Gas reported a 3% natural gas production decrease at Seneca Resources due to weather-related delays and natural declines, while moving forward with upgrades to its Line N pipeline to carry more Marcellus and Utica shale gas. This combination of softer near-term production and added pipeline capacity highlights how the company is balancing short-term operational challenges with longer-term infrastructure growth in its core...

Lucid Group (NasdaqGS:LCID) is deepening its partnership with Uber, with a US$1.05b capital raise and Uber lifting its stake to 11.5%. Uber has committed to purchase 35,000 Lucid vehicles as part of the agreement, linking Lucid more closely to future autonomous mobility platforms. The news comes as Lucid shifts toward operational turnaround under new CEO Silvio Napoli and addresses a stop sale on its Gravity model tied to supply chain issues. Lucid is also planning a push into more...

The Hanover Insurance Group recently approved a new US$700 million share repurchase authorization and expanded its motorcycle and off-road vehicle insurance offerings into several additional U.S. states, enhancing coverage features and availability. This combination of an enlarged buyback program and broader specialty product footprint highlights the company’s emphasis on capital deployment alongside deeper multi-product relationships with policyholders. We’ll now examine how Hanover’s...

PTC (NasdaqGS:PTC) has expanded its startup program globally, offering early and growth-stage startups in all industries free access to a suite of its professional-grade product development tools. The initiative aims to broaden PTC’s ecosystem and embed its cloud-based PLM and engineering software in emerging businesses worldwide. For investors following PTC, this move sits at the core of what the company does, providing product lifecycle management and engineering software to customers...

Investors may be wondering whether Xylem at around US$108.12 is offering good value right now, or if the price is running ahead of the fundamentals. The stock is down about 4.9% over the past week, 13.6% over the last month and 21.1% year to date, with a 14.5% decline over the past year, even though the 3 year return sits at 6.8% and the 5 year return is roughly flat at a 0.7% decline. Recent coverage has focused on how water infrastructure and related equipment fit into long term investment...

Xometry (XMTR) stock has been in focus after Siemens agreed to invest about US$50 million and embed Xometry’s manufacturing marketplace into its Xcelerator software, along with new data-center-focused manufacturing capabilities. See our latest analysis for Xometry. The Siemens partnership and raised 2026 guidance have coincided with a sharp shift in sentiment, with the share price at US$86.12 after a 30-day share price return of 87.22% and a very large 3-year total shareholder return of...

Recent price action and long term returns Americold Realty Trust (COLD) has seen mixed share performance recently, with the stock down about 2% over the past day and 4% over the past week, but up over the past month and past 3 months. Over longer horizons, the picture has been weaker, with total returns down about 16% over the past year, around 45% over 3 years, and roughly 54% over 5 years. This may influence how you weigh recent gains against prior declines. At a last close of US$14.26,...

What FMC’s India Exit Means For Investors FMC (FMC) has agreed to sell its India crop protection business to Crystal Crop Protection Limited, a move that responds directly to intense generic competition and limited profitability in that market. The deal, valued at US$252 million, shifts FMC away from direct commercial operations in India while keeping its R&D and manufacturing footprint in the country through a supply agreement with Crystal. See our latest analysis for FMC. Those moves sit...

Coherent (COHR) is back in focus after reporting third quarter sales of US$1.81b and net income of US$191.4m, alongside fresh revenue guidance and expanding AI focused partnerships with NVIDIA. See our latest analysis for Coherent. At a share price of US$382.45, Coherent has given investors a 24.09% 30 day share price return and a 96.80% year to date share price return. The 1 year total shareholder return is 386.58%, indicating momentum that has aligned with AI related earnings news and the...

Invivyd (IVVD) has released its Q1 2026 numbers with revenue of about US$13.7 million and a basic EPS loss of US$0.13, alongside a trailing 12 month net loss of US$77.6 million. The company has seen revenue move from US$25.4 million in Q4 2024 on a trailing 12 month basis to US$55.9 million in the latest trailing period, while trailing basic EPS has shifted from a loss of US$1.43 to a loss of US$0.35. Investors are therefore looking at a business where top line momentum is meeting still heavy...

Abbott Laboratories (ABT) is drawing fresh scrutiny after sales declines in its Nutrition business, new product launches and pricing moves, and early signs of recovering volumes, all while analysts grow more cautious on the stock. See our latest analysis for Abbott Laboratories. The share price has come under pressure despite the Exact Sciences acquisition and commentary around legal risks. The stock is down 16.83% on a 1 month share price return, and the 1 year total shareholder return has...

Recent share performance and context for Champion Homes Champion Homes (SKY) has drawn investor attention after a period of weaker share performance, with the stock down about 12% over the past month and about 31% over the past 3 months. That slide comes against a backdrop of positive reported annual revenue and net income growth. This leaves investors weighing how the current share price lines up with the company’s recent financial results and long term track record. See our latest analysis...

Griffon (GFF) has drawn fresh attention after shares closed at US$81.85, with recent returns mixed across different time frames, prompting investors to reassess the stock using its latest financial and valuation metrics. See our latest analysis for Griffon. Recent trading has been choppy, with the share price down 4.73% over the last session and 12.55% over 90 days. However, Griffon still shows a positive year-to-date share price return of 9.08% and a 5 year total shareholder return of...

Tyra Biosciences, Inc. recently reported first-quarter 2026 results showing a wider net loss of US$39.31 million and basic loss per share of US$0.64, while highlighting progress across three Phase 2 trials for its lead candidate dabogratinib and a cash balance of US$383.5 million supporting operations into the second half of 2028. An interesting angle for investors is how Tyra’s “dabogratinib 3×3” plan concentrates resources on three FGFR3-driven indications, potentially shaping its future...

Humacyte (HUMA) is back in focus after Q1 2026 results highlighted continued losses alongside restructuring moves, new leadership, fresh international agreements, and upcoming clinical readouts that could influence how investors view the stock. See our latest analysis for Humacyte. The share price has been volatile, with a 1 month share price return of 26.36% but a 1 year total shareholder return that is down 58.48%. This reflects shifting sentiment as investors weigh fresh capital raises,...

Recent attention on Home Depot (HD) has intensified as investors look ahead to the upcoming first quarter earnings release, while weighing legal scrutiny over parking lot surveillance and softer housing driven demand that has pressured the stock. See our latest analysis for Home Depot. The share price has come under clear pressure recently, down 12.2% over the past month and 23.9% over 90 days, while the 1 year total shareholder return is down 19.9%. Returns are still positive over 3 and 5...

Rubber Leaf (OTCPK:RLEA) opened 2026 with Q1 revenue of about US$3.3 million and basic EPS of roughly US$0.01, with the stock trading around US$4.50. Over recent periods, the company has seen quarterly revenue range from US$0 to about US$3.3 million while basic EPS has moved between a loss of roughly US$0.01 and a gain of just under US$0.01. This gives investors a clear view of how sensitive margins have been to shifts in activity levels. See our full analysis for Rubber Leaf. With the...

Why Clarivate’s New AI Platform Matters for the Stock Clarivate (CLVT) has launched Web of Science Research Intelligence, an AI-native platform built with research institutions to combine curated data, impact metrics, and workflows across funding, collaboration, and research assessment. For shareholders, this fresh product sits at the heart of Clarivate’s existing research and intellectual property data assets, raising questions about adoption, pricing power, and how it may influence...

Bright Horizons Family Solutions (BFAM) is back on investor radar after first quarter results met revenue expectations, full year guidance was reaffirmed, and the stock was added to several S&P indexes. See our latest analysis for Bright Horizons Family Solutions. Despite the recent index additions and reaffirmed guidance, the stock has come under pressure, with the 30 day share price return down 18.29% and the 1 year total shareholder return down 44.84%. This points to fading momentum after...

Old Dominion Freight Line (ODFL) has drawn fresh attention after reporting quarterly revenue of $1.33b, which declined 2.9% year on year but came in ahead of expectations, alongside accelerating less than truckload volumes and improved yield. See our latest analysis for Old Dominion Freight Line. At a share price of $203.12, Old Dominion Freight Line has delivered a 27.6% year to date share price return and a 19.42% total shareholder return over the past year, with shorter term moves...

Earlier this week, ASP Isotopes’ subsidiary Quantum Leap Energy disclosed a non-binding Memorandum of Understanding with a European advanced nuclear reactor developer to explore long-term supply of high assay low enriched uranium (HALEU), including feedstock, conversion, enrichment above 10% U‑235, and potential deliveries beginning between 2028 and 2030. This MOU highlights ASP Isotopes’ attempt to build a larger role in future advanced nuclear fuel supply chains by evaluating end‑to‑end...

Bentley Systems (BSY) has just launched NXT Activate with NXT BLD, a developer accelerator aimed at early stage AEC software startups, putting the company’s broader ecosystem strategy in sharper focus for investors. See our latest analysis for Bentley Systems. Despite the NXT Activate launch and recent first quarter earnings update, Bentley Systems’ share price is around US$32.07, with the 30 day share price return down 5.82% and the 1 year total shareholder return falling 32.73%. This hints...